ArticleHepatology international2025
Could the TAE score predicting the prognosis of unresectable HCC patients treated with TACE plus lenvatinib with PD-1 inhibitors be better if certain revisions are made?
Xijing Ma et al.PubMed ↗Publisher ↗
No numbers read from the abstract.